Creo Medical Group Plc (CREO) Ord GBP0.001

- Add to watchlist
- Create an alert
- This stock can be held in a




13.38p
13.50p
32.50p
£54.65 million
13.38p
13.00p
9.30p
n/a
0.25p (1.83%) Previous:
0.25p
303,475
n/a
30,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2024 | 31/12/2023 |
---|---|---|
Revenue (£m) | 4.00 | 4.00 |
Profit before tax (£m) | (29.00) | (26.40) |
Adjusted EPS (p): | (8.00) | (8.00) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Creo Medical's SpydrBlade Flex device receives US FDA clearance
11 June 2025 07:44
-
Creo Medical eyes transition to full commercialisation in FY25
17 February 2025 08:00
-
Director dealings: Creo Medical chairman raises stake
16 December 2024 15:27
-
Award of Shares under SIP and Director Dealings
24 July 2025 07:00
-
H1’25 Trading Update
21 July 2025 07:00
-
MicroBlate™ Flex begins lung tumour clinical study
10 July 2025 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.